Естония - естонски - Ravimiamet

intervet international b.v. - lindude nakkava bronhiidi viirusvaktsiin+newcastle'i tõve viirus-/paramüksoviirusvaktsiin - lüofilisaat okulonasaalsuspensiooni valmistamiseks/joogivees manustamiseks - 1000eid50+1000000eld50 1annus 2500annus 6tk; 1000eid50+1000000eld50 1annus 1000annus 1tk; 1000eid50+1000000eld50 1annus 5000annus 6tk; 1000eid50+1000000eld50 1annus 1000annus 12tk; 1000eid50+1000000eld50 1annus 1000annus 6tk; 1000eid50+1000000eld50 1annus 10000annus 12tk; 1000eid50+1000000eld50 1annus 5000annus 12tk; 1000eid50+1000000eld50 1annus 1000annus 10tk; 1000eid50+1000000eld50 1annus 10000annus 6tk; 1000eid50+1000000eld50 1annus 2500annus 10tk

Естония - естонски - Ravimiamet

intervet international b.v. - lindude nakkava bronhiidi viirusvaktsiin+newcastle'i tõve viirus-/paramüksoviirusvaktsiin+lindude reoviirusvaktsiin+lindude nakkava bursiidi (gumboro) viirusvaktsiin - süsteemulsioon - 6log2 hiu+50pd50+7,4log2 elisa+12,5log2 vn 0.5ml 500ml 1tk

Естония - естонски - Ravimiamet

intervet international b.v. - lindude nakkava bronhiidi viirusvaktsiin+newcastle'i tõve viirus-/paramüksoviirusvaktsiin+lindude nakkava bursiidi (gumboro) viirusvaktsiin - süsteemulsioon - 1annus 1000annus 1tk

Естония - естонски - Ravimiamet

intervet international b.v. - lindude nakkava bronhiidi viirusvaktsiin+newcastle'i tõve viirus-/paramüksoviirusvaktsiin+lindude nakkava bursiidi (gumboro) viirusvaktsiin - süstelahus - 4log2 hai.Ü+50pd50+12,5log2 vnÜ 1annus 1000annus 1tk

Естония - естонски - Ravimiamet

renew pharmaceuticals limited - indotsüaniinroheline - süstelahuse pulber - 25mg 5tk

Европейски съюз - естонски - EMA (European Medicines Agency)

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Европейски съюз - естонски - EMA (European Medicines Agency)

novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - hüpertensioon - reniini-angiotensiini süsteemi toimivad ained - essentsiaalse hüpertensiooni ravi. imprida on näidustatud patsientidele, kelle vererõhk ei ole adekvaatselt kontrollitav kohta amlodipine või valsartan monotherapy.

Европейски съюз - естонски - EMA (European Medicines Agency)

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Европейски съюз - естонски - EMA (European Medicines Agency)

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Естония - естонски - Ravimiamet

krka, d.d., novo mesto - losartaan+amlodipiin - õhukese polümeerikattega tablett - 50mg+5mg 10tk; 50mg+5mg 60tk; 50mg+5mg 56tk; 50mg+5mg 28tk; 50mg+5mg 84tk